CA
BMEZ icon

Clearstead Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Clearstead Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
6,666
+81
+1% +$1.17K ﹤0.01% 1286
2026
Q1 		$94.6K Buy
6,585
+78
+1% +$1.16K ﹤0.01% 1145
2025
Q4 		$97.9K Buy
6,507
+73
+1% +$1.1K ﹤0.01% 1137
2025
Q3 		$92.8K Buy
6,434
+115
+2% +$1.63K ﹤0.01% 1076
2025
Q2 		$90.1K Sell
6,319
-4,895
-44% -$70K ﹤0.01% 1096
2025
Q1 		$167K Buy
11,214
+6,205
+124% +$97.1K ﹤0.01% 873
2024
Q4 		$72.1K Sell
5,009
-10,400
-67% -$161K ﹤0.01% 1089
2024
Q3 		$244K Buy
15,409
+175
+1% +$2.76K ﹤0.01% 782
2024
Q2 		$234K Buy
+15,234
New +$231K ﹤0.01% 769

Other funds holding BMEZ

COLIM
City of London Investment Management London, United Kingdom $1.66B AUM 59.71% 1-Year Est. Return
AW
Atlas Wealth Cincinnati, Ohio $701M AUM 15.28% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.77B AUM

Clearstead Advisors's BMEZ Position: Q2 2026 in Review

Clearstead Advisors increased its BlackRock Health Sciences Trust II (BMEZ) stake by 1.2% in Q2 2026, buying an estimated $1.17K and bringing the position to 6,666 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Clearstead Advisors first reported a position in BMEZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $244K in Q3 2024. 44 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Clearstead Advisors held 6,666 shares of BlackRock Health Sciences Trust II worth $102K as of Q2 2026.
  • Clearstead Advisors bought 81 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $1.17K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1286 holding.
  • Clearstead Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2024 and has held it in 9 quarters since.
  • Clearstead Advisors's BlackRock Health Sciences Trust II position peaked at $244K in Q3 2024.
  • 44 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.